Stephen Herman
Co-Director, JDMI AI Centre
Dr. Steve Herman completed medical school and radiology residency at the University of Toronto and a fellowship in Thoracic Imaging at Harvard University.
He is currently Associate Professor of Medical Imaging at the University of Toronto. He’s a member of the Division of Cardiothoracic Imaging at JDMI which he joined in 1985. He is the Co-Founder and currently Co-Director of the JDMI AI Centre. Previously he created and led the Radiology Resident’s Research Program at U of T. He was also the inaugural head of the Division of Cardiothoracic Imaging at U of T.
His entrepreneurial activities include founding the companies Interpra (acquired by Merge Healthcare) and MedCurrent Corporation of which he is currently CEO.
- Low-dose computed tomography (LDCT) in workers previously exposed to asbestos: detection of parenchymal lung disease
CONCLUSIONS: Low-dose CT could demonstrate parenchymal lung manifestations in this higher-risk asymptomatic group with prior exposure to asbestos in […]
- Radiology decisions lead to cost savings. Point-of-order clinical decision-support solutions assure that medically appropriate procedures are given the highest priority
No abstract
- Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience
CONCLUSIONS: Data indicate that LDCT can identify small lung cancers in an at-risk population. The diagnostic algorithm results in few false-positive […]
- Does intensive follow-up alter outcome in patients with advanced lung cancer?
CONCLUSION: In patients with locally advanced NSCLC, frequent cross-sectional imaging does not alter survival after combined modality therapy.
- Forensic aspects of behavioral pediatrics
This article provided many situations in which the pediatrician may cross paths (if not swords) with members of the legal profession. It is extremely […]
- Value of CT in assessing probable severe acute respiratory syndrome
No abstract
- Trioxolanes: A new generation of compounds with wide-ranging activities
Direct biological activity of a 1,2,4-trioxolane derivative was assessed in vitro using bacteria and fungi causing common infections. The product was […]
- Self referral to consultants
No abstract